Clinical Pharmacology Practice Questions

Q: Sulfasalazine is NOT used for the treatment of which of the following conditions?

Sarcoidosis. **Explanation:** Sulfasalazine is a prodrug consisting of **5-aminosalicylic acid (5-ASA)** linked to **sulfapyridine** by a covalent azo bond. Its therapeutic utility is primarily derived from its anti-inflammatory and immunomodulatory properties. **Why Sarcoidosis is the Correct Answer:** Sarcoidosis is a multisystem granulomatous disease [2]. The mainstay of treatment for symptomatic sarcoidosis is **Corticosteroids** (e.g., Prednisolone). In steroid-resistant cases, second-line agents include Methotrexate, Azathioprine, or TNF-alpha inhibitors (Infliximab). Sulfasalazine has no established role in the management of sarcoidosis. **Analysis of Other Options:** * **Ulcerative Colitis (UC):** Sulfasalazine is a classic first-line agent for inducing and maintaining remission in mild-to-moderate UC [1]. The azo bond is cleaved by colonic bacteria, releasing 5-ASA (Mesalamine) directly at the site of colonic inflammation [1]. * **Crohn’s Disease:** While less effective than in UC (due to the transmural nature of Crohn's), Sulfasalazine is used for colonic involvement in Crohn’s disease [1]. * **Rheumatoid Arthritis (RA):** Sulfasalazine is classified as a **DMARD** (Disease-Modifying Anti-Rheumatic Drug). In RA, the sulfapyridine moiety is thought to be the active component responsible for systemic immunomodulation. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits prostaglandin synthesis and leukotriene production. * **Side Effects:** Reversible **oligospermia** (common MCQ), megaloblastic anemia (due to folate deficiency—always supplement folic acid), and hypersensitivity reactions (Stevens-Johnson Syndrome). * **Metabolism:** Acetylation in the liver. "Slow acetylators" are at a higher risk of toxicity. * **Monitoring:** Baseline and periodic CBC and LFTs are required.

Q: Coloured urine is not seen in which of the following medications?

Quinine. The correct answer is **Quinine**. [1] **1. Why Quinine is the correct answer:** Quinine, an alkaloid used in the treatment of malaria, does not typically cause discoloration of the urine as a direct pharmacological effect [1]. However, it is famously associated with **"Blackwater Fever"** (massive intravascular hemolysis in *P. falciparum* malaria), which leads to hemoglobinuria (dark/black urine) [2]. In this context, the color change is a result of a pathological complication (hemolysis), not a direct property of the drug itself. **2. Analysis of Incorrect Options:** * **Rifampicin:** A classic high-yield fact. It causes a harmless **orange-red** discoloration of urine, sweat, tears, and saliva. Patients must be counseled about this to prevent poor compliance. * **Nitrofurantoin:** This urinary antiseptic commonly causes the urine to turn **brown or dark yellow**. * **Pyridium (Phenazopyridine):** Used as a urinary analgesic for cystitis, it characteristically turns urine a bright **orange to reddish-orange**. It can also stain contact lenses. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Red/Orange Urine:** Rifampicin, Phenazopyridine, Anthracyclines (Doxorubicin), Laxatives (Senna/Phenolphthalein). * **Brown/Black Urine:** Nitrofurantoin, Metronidazole, L-Dopa, Methyldopa, Chloroquine, Alkaptonuria (on standing). * **Blue/Green Urine:** Methylene blue, Amitriptyline, Propofol, Triamterene, Pseudomonas infection. * **Milky White Urine:** Chyluria (Filariasis), Phosphaturia. **Key Takeaway:** Always distinguish between a drug's direct pigmentary effect (Rifampicin) and a pathological complication (Quinine-induced hemolysis).

Q: Which drug is preferred for management of diabetes in a patient with cardiac and renal failure?

SGLT2 inhibitors. ***SGLT2 inhibitors*** - These agents are strongly recommended due to their proven benefits in reducing **heart failure (HF)** hospitalizations and **cardiovascular (CV) mortality**. - They also offer robust **reno-protection**, slowing the decline of **eGFR** and reducing albuminuria, making them ideal when both cardiac and renal failure coexist. *Pioglitazone* - This drug class (**thiazolidinediones**) is known to cause **fluid retention** and peripheral edema, thus potentially exacerbating or precipitating **congestive heart failure (CHF)**; it is therefore generally avoided [1]. - It is not associated with improved long-term renal or cardiovascular outcomes in the way that SGLT2 inhibitors are. *Metformin* - While a foundational drug, Metformin is contraindicated in severe **renal failure** (e.g., eGFR <30 mL/min/1.73m²) due to the increased risk of potentially fatal **lactic acidosis**. - Although safe in mild to moderate CKD, it lacks the specific, compelling evidence for reducing progression of **heart failure** or **CKD** compared to SGLT2 inhibitors. *Sulfonylureas* - These drugs primarily increase the risk of **hypoglycemia**, which is heightened in patients with **renal insufficiency** due to altered drug metabolism and clearance. - They provide no demonstrated **cardiovascular** or **renal protective benefits** and may be associated with weight gain.

Q: For a 40 year old hypertensive woman, which one of the following is not recommended for contraception?

NuvaRing. ***NuvaRing*** - **NuvaRing** is a **combined hormonal contraceptive** that releases both estrogen and progestin. - **Estrogen-containing contraception** is generally **contraindicated** or used with caution in women with uncontrolled hypertension due to an increased risk of **cardiovascular events** such as stroke and myocardial infarction. *IUCD* - **Intrauterine contraceptive devices (IUCDs)**, both copper and levonorgestrel-releasing, are considered **safe** and highly effective for women with hypertension. - They do not contain systemic hormones or contain only progestin, which has a minimal impact on blood pressure. *Minipill* - The **minipill** is a **progestin-only oral contraceptive**. - **Progestin-only contraceptives** are safe for women with hypertension as they do not carry the same cardiovascular risks associated with estrogen. *LNG IUD (LNg IUD)* - The **levonorgestrel-releasing intrauterine device (LNG IUD)** is a **progestin-only contraceptive**. - It is **safe** for women with hypertension because the progestin is primarily local, and it does not contain estrogen, thereby avoiding cardiovascular risks.

Q: The initial prevention strategy for antiphospholipid syndrome will be: 1. Steroids 2. Heparin 3. Low dose aspirin 4. Progesterone support Which of the above is/are correct?

2 and 3. ***2 and 3*** - For pregnant women with antiphospholipid syndrome (APS), a combination of **low-dose aspirin** and **low molecular weight heparin (LMWH)** or **unfractionated heparin (UFH)** is the most widely accepted and effective initial prevention strategy to prevent pregnancy complications. - **Low-dose aspirin** helps reduce platelet aggregation, while **heparin** inhibits coagulation, addressing both thrombotic tendencies associated with APS. *1 and 4* - **Steroids** are typically reserved for severe manifestations of APS, such as catastrophic APS or refractory cases, and are not part of the initial standard preventative regimen. - **Progesterone support** is indicated for threatened miscarriage or luteal phase defect but does not address the underlying thrombotic risk in APS for pregnancy prevention. *3 only* - While **low-dose aspirin** is an important component, it is insufficient on its own for preventing pregnancy complications in women with antiphospholipid syndrome due to the high thrombotic risk. - **Heparin**, either LMWH or UFH, is crucial to provide adequate anticoagulation and is always used in conjunction with aspirin for initial prevention. *3 and 4* - **Low-dose aspirin** is appropriate, but **progesterone support** (4) is not a primary measure for preventing thrombotic events or pregnancy complications specifically linked to antiphospholipid syndrome. - The critical missing component in this option is **heparin**, which is essential for anticoagulation in APS pregnancies.

Q: A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

Adequate initial hydration. Adequate initial hydration - Intravenous (IV) acyclovir is associated with **nephrotoxicity** due to the formation of **insoluble acyclovir crystals** in the renal tubules, especially in states of dehydration. - **Maintaining adequate hydration** helps in diluting the drug and preventing crystal precipitation, thereby protecting renal function. [1] *Initial administration of allopurinol* - **Allopurinol** is used to prevent **uric acid nephropathy**, typically seen in **tumor lysis syndrome**, not acyclovir-induced crystal nephropathy. [2] - Its administration would not have prevented the formation of **acyclovir crystals**. *Initial administration of glucocorticoids* - **Glucocorticoids** are potent anti-inflammatory agents but do not prevent **drug-induced crystal formation** or directly protect against acyclovir nephrotoxicity. - They are primarily used for inflammatory conditions or to suppress immune responses. *Monitoring of drug levels* - While drug level monitoring can be useful for certain medications to prevent toxicity, it's not the primary preventative measure for **acyclovir-induced crystal nephropathy**. - **Hydration** is more immediate and effective in preventing crystal precipitation. *Obtaining a thorough history of patient allergies* - An allergy history is crucial for preventing **hypersensitivity reactions** to medications, but it would not prevent **nephrotoxicity** due to crystal formation, which is a pharmacokinetic phenomenon. - The patient's renal deterioration is due to **acyclovir crystal nephropathy**, not an allergic reaction.

Q: The contraceptive which is contraindicated in DVT is?

OCP. ***OCP*** - **Oral contraceptive pills (OCPs)**, especially those containing estrogen, increase the risk of **venous thromboembolism (VTE)**, including deep vein thrombosis (DVT). - Estrogen promotes a **hypercoagulable state** by increasing clotting factors and decreasing natural anticoagulants. *Barrier method* - **Barrier methods** like condoms or diaphragms are non-hormonal and act physically to prevent sperm from reaching the egg. - They have **no systemic effects** on coagulation and are safe for individuals with DVT. *Non hormonal IUCD* - **Non-hormonal intrauterine contraceptive devices (IUCDs)**, such as copper IUCDs, prevent conception primarily by causing a local inflammatory reaction in the uterus. - They do not release hormones and therefore **do not affect coagulation** or increase DVT risk. *Billing's method* - The **Billing's ovulation method** (cervical mucus method) is a natural family planning technique based on observing changes in cervical mucus. - It involves no medications or devices and thus has **no impact on DVT risk**.

Q: Which of the following is the most appropriate initial antihypertensive treatment for an elderly patient with isolated systolic hypertension?

Amlodipine. Amlodipine - **Calcium channel blockers (CCBs)**, especially dihydropyridines like amlodipine, are recommended as initial therapy for isolated systolic hypertension in the elderly due to their effectiveness in reducing elevated systolic pressure [2]. - They are well-tolerated and can reduce the risk of cardiovascular events in this population. *Lisinopril* - **ACE inhibitors** like lisinopril are effective antihypertensives but are generally not the first-line choice for isolated systolic hypertension, particularly in elderly patients where a decrease in diastolic pressure might be detrimental [1]. - They are associated with side effects such as **cough** and can cause **acute kidney injury**, which can be a concern in older adults [1]. Atenolol - **Beta-blockers** like atenolol are generally not recommended as first-line therapy for isolated systolic hypertension due to their limited efficacy in lowering systolic blood pressure compared to other drug classes. - They may also worsen certain conditions common in the elderly, such as **peripheral vascular disease** and **bronchospastic lung disease**. *Losartan* - **Angiotensin receptor blockers (ARBs)** like losartan are effective for hypertension but are not typically favored over CCBs or thiazide diuretics as initial monotherapy for isolated systolic hypertension in the elderly [1]. - They share similar side effects and contraindications with ACE inhibitors, including the risk of **renal dysfunction** [1].

Question 1

Sulfasalazine is NOT used for the treatment of which of the following conditions?

Accepted Answer

Sarcoidosis

Answer

Crohn's disease

Answer

Rheumatoid arthritis

Answer

Ulcerative colitis

Question 2

Coloured urine is not seen in which of the following medications?

Accepted Answer

Quinine

Answer

Rifampicin

Answer

Nitrofurantoin

Answer

Pyridium

Question 3

Which drug is preferred for management of diabetes in a patient with cardiac and renal failure?

Accepted Answer

SGLT2 inhibitors

Answer

Pioglitazone

Answer

Metformin

Answer

Sulfonylureas

Question 4

For a 40 year old hypertensive woman, which one of the following is not recommended for contraception?

Accepted Answer

NuvaRing

Answer

IUCD

Answer

Minipill

Answer

LNG IUD (LNg IUD)

Question 5

The initial prevention strategy for antiphospholipid syndrome will be:
1. Steroids
2. Heparin
3. Low dose aspirin
4. Progesterone support
Which of the above is/are correct?

Accepted Answer

2 and 3

Answer

1 and 4

Answer

3 only

Answer

3 and 4

Question 6

A 66-year-old woman presents to the emergency department after a fall 4 hours ago. She was on her way to the bathroom when she fell to the ground and lost consciousness. Although she regained consciousness within one minute, she experienced lightheadedness for almost half an hour. She has experienced on-and-off dizziness for the past 2 weeks whenever she tries to stand. She has a history of type 2 diabetes mellitus, hypertension, hypercholesterolemia, and chronic kidney disease secondary to polycystic kidneys. Her medications include aspirin, bisoprolol, doxazosin, erythropoietin, insulin, rosuvastatin, and calcium and vitamin D supplements. She has a blood pressure of 111/74 mm Hg while supine and 84/60 mm Hg on standing, the heart rate of 48/min, the respiratory rate of 14/min, and the temperature of 37.0°C (98.6°F). CT scan of the head is unremarkable. Electrocardiogram reveals a PR interval of 250 ms. What is the next best step in the management of this patient?

Accepted Answer

Stop antihypertensive medicines

Answer

Tilt table testing

Answer

Holter monitoring

Answer

Electroencephalogram

Answer

Start anti-epileptics

Question 7

A 35-year-old man with a past medical history of HIV is hospitalized with a disseminated zoster infection and treated with IV acyclovir. His course of illness worsens on the 4th day after admission and his creatinine level increases to 4.2 mg/dL. Urinalysis shows birefringent needle-shaped crystals. What could have prevented this deterioration in the patient's renal function?

Accepted Answer

Adequate initial hydration

Answer

Initial administration of allopurinol

Answer

Initial administration of glucocorticoids

Answer

Monitoring of drug levels

Answer

Obtaining a thorough history of patient allergies

Question 8

The contraceptive which is contraindicated in DVT is?

Accepted Answer

OCP

Answer

Barrier method

Answer

Non hormonal IUCD

Answer

Billing's method

Question 9

Which of the following is the most appropriate initial antihypertensive treatment for an elderly patient with isolated systolic hypertension?

Accepted Answer

Amlodipine

Answer

Lisinopril

Answer

Atenolol

Answer

Losartan

Question 10

Megaloblastic anemia should be treated with both folic acid and vitamin B12 because -

Accepted Answer

Folic acid alone causes improvement of hematologic symptoms but worsening of neurological symptoms

Answer

It is an enzyme

Answer

It is a cofactor

Answer

None of the above

Clinical Pharmacology — MCQs

Clinical Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?